S&P 500   4,008.01
DOW   32,223.42
QQQ   298.44
WD-40 Stock is Ready to Coil like a Piston
In Ukraine and internationally, scenario darkens for Russia
Recession Fears Mount After Weak Manufacturing Data
F5 Inc Is a Troubled Stock With Upside Potential
Warby Parker Stock Is A High-Probability Candidate For A Short-Squeeze 
CarMax Stock is Poised to Bounce
Get on your bike: Coldplay hopes to lead with a green tour
S&P 500   4,008.01
DOW   32,223.42
QQQ   298.44
WD-40 Stock is Ready to Coil like a Piston
In Ukraine and internationally, scenario darkens for Russia
Recession Fears Mount After Weak Manufacturing Data
F5 Inc Is a Troubled Stock With Upside Potential
Warby Parker Stock Is A High-Probability Candidate For A Short-Squeeze 
CarMax Stock is Poised to Bounce
Get on your bike: Coldplay hopes to lead with a green tour
S&P 500   4,008.01
DOW   32,223.42
QQQ   298.44
WD-40 Stock is Ready to Coil like a Piston
In Ukraine and internationally, scenario darkens for Russia
Recession Fears Mount After Weak Manufacturing Data
F5 Inc Is a Troubled Stock With Upside Potential
Warby Parker Stock Is A High-Probability Candidate For A Short-Squeeze 
CarMax Stock is Poised to Bounce
Get on your bike: Coldplay hopes to lead with a green tour
S&P 500   4,008.01
DOW   32,223.42
QQQ   298.44
WD-40 Stock is Ready to Coil like a Piston
In Ukraine and internationally, scenario darkens for Russia
Recession Fears Mount After Weak Manufacturing Data
F5 Inc Is a Troubled Stock With Upside Potential
Warby Parker Stock Is A High-Probability Candidate For A Short-Squeeze 
CarMax Stock is Poised to Bounce
Get on your bike: Coldplay hopes to lead with a green tour
NYSE:JNJ

Johnson & Johnson (JNJ) Stock Forecast, Price & News

$178.08
+1.23 (+0.70%)
(As of 05/16/2022 12:00 AM ET)
Add
Compare
Today's Range
$176.17
▼
$179.13
50-Day Range
$169.35
▼
$186.01
52-Week Range
$155.72
▼
$186.69
Volume
5.41 million shs
Average Volume
8.17 million shs
Market Capitalization
$468.60 billion
P/E Ratio
24.00
Dividend Yield
2.40%
Beta
0.66
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive JNJ News and Ratings via Email

Sign-up to receive the latest news and ratings for Johnson & Johnson and its competitors with MarketBeat's FREE daily newsletter.

Johnson & Johnson logo

About Johnson & Johnson

Johnson & Johnson researches and develops, manufactures, and sells various products in the healthcare field worldwide. It operates in three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and healthcare professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Headlines

May 12, 2022 | marketbeat.com
South African firm says it may close its COVID vaccine plant
The first factory to produce COVID-19 vaccines in Africa has announced that it has not received enough orders and is planning to stop production within a few weeks, in what a senior World Health Organization official described as a “failure” in efforts to achieve vaccine equity
May 5, 2022 | marketbeat.com
FDA restricts J&J's COVID-19 vaccine due to blood clot risk
U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots
May 3, 2022 | marketbeat.com
Washington reaches $518M settlement with opioid distributors
Months into a complex trial over their role in flooding Washington with highly addictive painkillers, the nation’s three largest opioid distributors have agreed to pay the state $518 million
April 24, 2022 | marketbeat.com
How Long Could $500K Last? Forever, with These Stocks.
April 20, 2022 | marketbeat.com
Highly Valued Abbot Laboratories Could Move Lower (JNJ)
Abbott Laboratories (NYSE: ABT) is not in danger of losing its business but we have some concerns its share price could fall. Not only is it a highly-valued stock compared to peers but its current revenue and earnings are based largely on COVID-19.
April 19, 2022 | marketbeat.com
Tech stocks rally after an early loss, leading market higher
Stocks rose broadly in afternoon trading on Wall Street Tuesday as technology stocks rallied following a weak start
April 19, 2022 | marketbeat.com
Stocks rise broadly as tech reverses course and rallies
Stocks rose broadly in afternoon trading on Wall Street Tuesday as technology stocks rallied following a weak start
April 19, 2022 | marketbeat.com
Stocks rise as Wall Street reviews latest company earnings
Stocks rose in morning trading on Wall Street Tuesday as investors continue reviewing earnings reports from big companies
April 19, 2022 | marketbeat.com
Workhorse Johnson & Johnson Plows New All-Time Highs
Johnson & Johnson (NYSE: JNJ) is, if nothing else, a workhorse among stocks and one any investor could own. The company’s business is more than entrenched, it often trades at a discount to the S&P 500, it delivers steady consistent growth, and it pays a nice dividend.
April 19, 2022 | marketbeat.com
Stocks open higher, but tech weakness holds gains in check
Stocks are opening mostly higher on Wall Street Tuesday as more earnings reports from big companies roll in
May 14, 2022 | seekingalpha.com
Johnson & Johnson: Priced About Right
May 14, 2022 | investorplace.com
Johnson & Johnson Stock: A Rare Bright Spot in the Market
May 13, 2022 | seekingalpha.com
Focus On Fundamentals In Stormy Markets: Johnson & Johnson
See More Headlines

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
NYSE:JNJ
Previous Symbol
CUSIP
47816010
CIK
200406
Web
www.jnj.com
Phone
(732) 524-0400
Fax
732-214-0332
Employees
141,700
Year Founded
1886

Sales & Book Value

Annual Sales
$93.78 billion
Price / Sales
5.00
Cash Flow
$12.85 per share
Price / Cash Flow
13.86
Book Value
$28.12 per share
Price / Book
6.33

Profitability

EPS (Most Recent Fiscal Year)
$7.419990
Net Income
$20.88 billion
Net Margins
20.90%
Pretax Margin
22.35%
Return on Equity
36.59%
Return on Assets
14.75%

Debt

Debt-to-Equity Ratio
0.39
Current Ratio
1.39
Quick Ratio
1.14

Price-To-Earnings

Trailing P/E Ratio
24.00
Forward P/E Ratio
17.46
P/E Growth
2.92

Miscellaneous

Outstanding Shares
2,631,400,000
Free Float
2,622,192,000
Market Cap
$468.60 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 3/8 Dividend
2/18/2022
Dividend Payable
3/08/2022
Last Earnings
4/19/2022
Today
5/16/2022
Ex-Dividend for 6/7 Dividend
5/23/2022
Dividend Payable
6/07/2022
Next Earnings (Estimated)
7/20/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank™

Overall MarketRank™

2.79 out of 5 stars

Medical Sector

28th out of 1,423 stocks

Pharmaceutical Preparations Industry

7th out of 678 stocks

Analyst Opinion: 2.3Community Rank: 4.4Dividend Strength: 4.2Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -













Johnson & Johnson (NYSE:JNJ) Frequently Asked Questions

Is Johnson & Johnson a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Johnson & Johnson stock.
View analyst ratings for Johnson & Johnson or view top-rated stocks.

When is Johnson & Johnson's next earnings date?

Johnson & Johnson is scheduled to release its next quarterly earnings announcement on Wednesday, July 20th 2022.
View our earnings forecast for Johnson & Johnson.

How were Johnson & Johnson's earnings last quarter?

Johnson & Johnson (NYSE:JNJ) posted its earnings results on Tuesday, April, 19th. The company reported $2.67 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.60 by $0.07. The company earned $23.43 billion during the quarter, compared to the consensus estimate of $23.62 billion. Johnson & Johnson had a trailing twelve-month return on equity of 36.59% and a net margin of 20.90%. The business's quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.59 EPS.
View Johnson & Johnson's earnings history.

How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?

Johnson & Johnson announced a quarterly dividend on Tuesday, April 19th. Shareholders of record on Tuesday, May 24th will be given a dividend of $1.13 per share on Tuesday, June 7th. This represents a $4.52 dividend on an annualized basis and a dividend yield of 2.54%. The ex-dividend date is Monday, May 23rd. This is a boost from Johnson & Johnson's previous quarterly dividend of $1.06.
View Johnson & Johnson's dividend history.

Is Johnson & Johnson a good dividend stock?

Johnson & Johnson pays an annual dividend of $4.24 per share and currently has a dividend yield of 2.40%. Johnson & Johnson has been increasing its dividend for 61 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Johnson & Johnson is 57.14%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Johnson & Johnson will have a dividend payout ratio of 39.44% next year. This indicates that Johnson & Johnson will be able to sustain or increase its dividend.
View Johnson & Johnson's dividend history.

What guidance has Johnson & Johnson issued on next quarter's earnings?

Johnson & Johnson issued an update on its FY 2022 earnings guidance on Tuesday, April, 26th. The company provided earnings per share (EPS) guidance of $10.150-$10.350 for the period, compared to the consensus EPS estimate of $10.520. The company issued revenue guidance of $94.80 billion-$95.80 billion, compared to the consensus revenue estimate of $99.48 billion.

What price target have analysts set for JNJ?

9 brokers have issued 12 month target prices for Johnson & Johnson's stock. Their forecasts range from $173.00 to $210.00. On average, they expect Johnson & Johnson's share price to reach $191.33 in the next year. This suggests a possible upside of 7.4% from the stock's current price.
View analysts' price targets for Johnson & Johnson or view top-rated stocks among Wall Street analysts.

Who are Johnson & Johnson's key executives?
Johnson & Johnson's management team includes the following people:
  • Mr. Alex Gorsky, Exec. Chairman (Age 62, Pay $6.18M)
  • Mr. Joaquin Duato, CEO & Director (Age 59, Pay $3.53M)
  • Mr. Joseph J. Wolk CPA, Exec. VP & CFO (Age 55, Pay $2.58M)
  • Ms. Jennifer L. Taubert, Exec. VP & Worldwide Chairman of Pharmaceuticals (Age 58, Pay $2.5M)
  • Mr. Robert J. Decker Jr., Controller & Chief Accounting Officer (Age 50) (LinkedIn Profile)
  • Mr. James Swanson, Exec. VP & Chief Information Officer
  • Ms. Jessica Moore, VP of Investor Relations
  • Mr. Michael H. Ullmann, Exec. VP & Gen. Counsel (Age 63)
  • Dr. Peter M. Fasolo Ph.D., Exec. VP & Chief HR Officer (Age 59)
  • Dr. Guy J. Lebeau M.D., Group Chairman of MD&D Bus. - EMEA
What is Alex Gorsky's approval rating as Johnson & Johnson's CEO?

2,535 employees have rated Johnson & Johnson CEO Alex Gorsky on Glassdoor.com. Alex Gorsky has an approval rating of 94% among Johnson & Johnson's employees. This puts Alex Gorsky in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Johnson & Johnson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Pfizer (PFE), Verizon Communications (VZ), Walt Disney (DIS), NVIDIA (NVDA), Intel (INTC), JPMorgan Chase & Co. (JPM), Cisco Systems (CSCO), Procter & Gamble (PG) and AbbVie (ABBV).

What is Johnson & Johnson's stock symbol?

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

Who are Johnson & Johnson's major shareholders?

Johnson & Johnson's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.05%), BlackRock Inc. (7.63%), State Street Corp (5.40%), Northern Trust Corp (1.29%), Wellington Management Group LLP (1.25%) and Bank of New York Mellon Corp (1.22%). Company insiders that own Johnson & Johnson stock include Ashley Mcevoy, Kathryn E Wengel, Michael E Sneed, Robert J Decker, Thibaut Mongon and William Hait.
View institutional ownership trends for Johnson & Johnson.

Which major investors are selling Johnson & Johnson stock?

JNJ stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, State Street Corp, Banque Pictet & Cie SA, Dimensional Fund Advisors LP, Nordea Investment Management AB, Assenagon Asset Management S.A., Flossbach Von Storch AG, and Toronto Dominion Bank. Company insiders that have sold Johnson & Johnson company stock in the last year include Robert J Decker, Thibaut Mongon, and William Hait.
View insider buying and selling activity for Johnson & Johnson or view top insider-selling stocks.

Which major investors are buying Johnson & Johnson stock?

JNJ stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc., GQG Partners LLC, Arrowstreet Capital Limited Partnership, Swiss National Bank, Bridgewater Associates LP, Vaughan Nelson Investment Management L.P., Verity Asset Management Inc., and First Trust Advisors LP.
View insider buying and selling activity for Johnson & Johnson or or view top insider-buying stocks.

How do I buy shares of Johnson & Johnson?

Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Johnson & Johnson's stock price today?

One share of JNJ stock can currently be purchased for approximately $178.08.

How much money does Johnson & Johnson make?

Johnson & Johnson has a market capitalization of $468.60 billion and generates $93.78 billion in revenue each year. The company earns $20.88 billion in net income (profit) each year or $7.419990 on an earnings per share basis.

How many employees does Johnson & Johnson have?

Johnson & Johnson employs 141,700 workers across the globe.

Does Johnson & Johnson have any subsidiaries?

The following companies are subsidiares of Johnson & Johnson: 3Dintegrated ApS, ALZA Corporation, AMO (Hangzhou) Co. Ltd., AMO (Shanghai) Medical Devices Trading Co. Ltd., AMO ASIA LIMITED, AMO Australia Pty Limited, AMO Canada Company, AMO Denmark ApS, AMO Development LLC, AMO France, AMO Germany GmbH, AMO Groningen B.V., AMO International Holdings, AMO Ireland, AMO Ireland Finance Unlimited Company, AMO Italy SRL, AMO Japan K.K., AMO Manufacturing Spain S.L., AMO Manufacturing USA LLC, AMO Netherlands BV, AMO Nominee Holdings LLC, AMO Norway AS, AMO Puerto Rico Manufacturing Inc., AMO Sales and Service Inc., AMO Singapore Pte. Ltd., AMO Spain Holdings LLC, AMO Switzerland GmbH, AMO U.K. Holdings LLC, AMO US Holdings Inc., AMO USA LLC, AMO USA Sales Holdings Inc., AMO United Kingdom Ltd., AMO Uppsala AB, APSIS, AUB Holdings LLC, Abott Medical Optics, Acclarent Inc., Actelion Ltd, Actelion Manufacturing GmbH, Actelion Pharmaceuticals, Actelion Pharmaceuticals Australia Pty. Limited, Actelion Pharmaceuticals Korea Ltd., Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals Mexico S.A. De C.V., Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd., Actelion Pharmaceuticals UK Limited, Actelion Pharmaceuticals US Inc., Actelion Registration Limited, Actelion Treasury Unlimited Company, Akros Medical Inc., Albany Street LLC, Alios BioPharma, Alza Land Management Inc., Animas Diabetes Care LLC, Animas LLC, Animas Technologies LLC, AorTx Inc., Aragon Pharmaceuticals, Aragon Pharmaceuticals Inc., Asia Pacific Holdings LLC, Atrionix Inc., Auris Health, Auris Health Inc., Backsvalan 2 Aktiebolag, Backsvalan 6 Handelsbolag, Beijing Dabao Cosmetics Co. Ltd., BeneVir BioPharm Inc., Berna Rhein B.V., BioMedical Enterprises Inc., Biosense Webster (Israel) Ltd., Biosense Webster Inc., C Consumer Products Denmark ApS, CNA Development GmbH, CSATS Inc., Calibra Medical LLC, Campus-Foyer Apotheke GmbH, Carlo Erba OTC S.r.l., Centocor Biologics LLC, Centocor Research & Development Inc., ChromaGenics B.V., Ci:Labo Customer Marketing Co. Ltd., Ci:z Holdings, Ci:z. Labo Co. Ltd., Cilag AG, Cilag GmbH International, Cilag Holding AG, Cilag Holding Treasury Unlimited Company, Cilag-Biotech S.L., CoTherix Inc., Codman & Shurtleff Inc., Coherex Medical Inc., ColBar LifeScience Ltd., Company Store.com Inc., Conor MedSystems, Cordis International Corporation, Cordis de Mexico S.A. de C.V., Corimmun GmbH, DR. CI:LABO COMPANY LIMITED, Darlain Trading S.A., DePuy France, DePuy Hellas SA, DePuy International Limited, DePuy Ireland Unlimited Company, DePuy Mexico S.A. de C.V., DePuy Mitek LLC, DePuy Orthopaedics Inc., DePuy Products Inc., DePuy Spine LLC, DePuy Synthes Gorgan Limited, DePuy Synthes Inc., DePuy Synthes Institute LLC, DePuy Synthes Leto SARL, DePuy Synthes Products Inc., DePuy Synthes Sales Inc., Debs-Vogue Corporation (Proprietary) Limited, Dr. Ci:Labo Co. Ltd., Dutch Holding LLC, ECL7 LLC, EES Holdings de Mexico S. de R.L. de C.V., EES S.A. de C.V., EIT Emerging Implant Technologies GmbH, Ethicon Biosurgery Ireland, Ethicon Endo-Surgery (Europe) GmbH, Ethicon Endo-Surgery Inc., Ethicon Endo-Surgery LLC, Ethicon Holding Sarl, Ethicon Inc., Ethicon Ireland Unlimited Company, Ethicon LLC, Ethicon PR Holdings Unlimited Company, Ethicon Sarl, Ethicon US LLC, Ethicon Women's Health & Urology Sarl, Ethnor (Proprietary) Limited, Ethnor Farmaceutica S.A., Ethnor Guatemala Sociedad Anomina, Ethnor del Istmo S.A., FMS Future Medical System SA, Finsbury (Development) Limited, Finsbury (Instruments) Limited, Finsbury Medical Limited, Finsbury Orthopaedics International Limited, Finsbury Orthopaedics Limited, GH Biotech Holdings Limited, GMED Healthcare BV, Global Investment Participation B.V., Guangzhou Bioseal Biotech Co. Ltd., Hansen Medical Deutschland GmbH, Hansen Medical Inc., Hansen Medical International Inc., Hansen Medical UK Limited, Healthcare Services (Shanghai) Ltd., I.D. Acquisition Corp., Innomedic Gesellschaft für innovative Medizintechnik und Informatik mbH, Innovalens B.V., Innovative Surgical Solutions LLC, J & J Company West Africa Limited, J&J Pension Trustees Limited, J-C Health Care Ltd., J.C. General Services BV, JJ Surgical Vision Spain S.L., JJC Acquisition Company B.V., JJHC LLC, JJSV Belgium BV, JJSV Manufacturing Malaysia SDN. BHD., JJSV Norden AB, JJSV Produtos Oticos Ltda., JNJ Global Business Services s.r.o., JNJ Holding EMEA B.V., JNJ International Investment LLC, JNJ Irish Investments ULC, JOM Pharmaceutical Services Inc., Janssen Alzheimer Immunotherapy (Holding) Limited, Janssen BioPharma Inc., Janssen Biologics (Ireland) Limited, Janssen Biologics B.V., Janssen Biotech Inc., Janssen Cilag C.A., Janssen Cilag Farmaceutica S.A., Janssen Cilag S.p.A., Janssen Cilag SPA, Janssen Development Finance Unlimited Company, Janssen Diagnostics LLC, Janssen Egypt LLC, Janssen Farmaceutica Portugal Lda, Janssen Global Services LLC, Janssen Group Holdings Limited, Janssen Holding GmbH, Janssen Inc., Janssen Irish Finance Company UC, Janssen Korea Ltd., Janssen Oncology Inc., Janssen Ortho LLC, Janssen Pharmaceutica (Proprietary) Limited, Janssen Pharmaceutica NV, Janssen Pharmaceutica S.A., Janssen Pharmaceutical, Janssen Pharmaceutical K.K., Janssen Pharmaceutical Sciences Unlimited Company, Janssen Pharmaceuticals Inc., Janssen Products LP, Janssen R&D Ireland, Janssen Research & Development LLC, Janssen Sciences Ireland Unlimited Company, Janssen Scientific Affairs LLC, Janssen Supply Group LLC, Janssen Vaccines & Prevention B.V., Janssen Vaccines Corp., Janssen de Mexico S. de R.L. de C.V., Janssen-Cilag, Janssen-Cilag (New Zealand) Limited, Janssen-Cilag A/S, Janssen-Cilag AG, Janssen-Cilag AS, Janssen-Cilag Aktiebolag, Janssen-Cilag B.V., Janssen-Cilag Farmaceutica Lda., Janssen-Cilag Farmaceutica Ltda., Janssen-Cilag GmbH, Janssen-Cilag International NV, Janssen-Cilag Kft., Janssen-Cilag Limited, Janssen-Cilag Manufacturing LLC, Janssen-Cilag NV, Janssen-Cilag OY, Janssen-Cilag Pharma GmbH, Janssen-Cilag Pharmaceutical S.A.C.I., Janssen-Cilag Polska Sp. z o.o., Janssen-Cilag Pty Ltd, Janssen-Cilag S.A., Janssen-Cilag S.A., Janssen-Cilag S.A. de C.V., Janssen-Cilag de Mexico S. de R.L. de C.V., Janssen-Cilag s.r.o., Janssen-Pharma S.L., Jevco Holding Inc., Johnson & Johnson, Johnson & Johnson (Angola) Limitada, Johnson & Johnson (China) Investment Ltd., Johnson & Johnson (Egypt) S.A.E., Johnson & Johnson (Hong Kong) Limited, Johnson & Johnson (Ireland) Limited, Johnson & Johnson (Jamaica) Limited, Johnson & Johnson (Kenya) Limited, Johnson & Johnson (Middle East) Inc., Johnson & Johnson (Mozambique) Limitada, Johnson & Johnson (Namibia) (Proprietary) Limited, Johnson & Johnson (New Zealand) Limited, Johnson & Johnson (Philippines) Inc., Johnson & Johnson (Private) Limited, Johnson & Johnson (Thailand) Ltd., Johnson & Johnson (Trinidad) Limited, Johnson & Johnson (Vietnam) Co. Ltd, Johnson & Johnson - Societa' Per Azioni, Johnson & Johnson AB, Johnson & Johnson AG, Johnson & Johnson Belgium Finance Company BV, Johnson & Johnson Bulgaria EOOD, Johnson & Johnson China Ltd., Johnson & Johnson Consumer (Hong Kong) Limited, Johnson & Johnson Consumer (Thailand) Limited, Johnson & Johnson Consumer B.V., Johnson & Johnson Consumer Holdings France, Johnson & Johnson Consumer Inc., Johnson & Johnson Consumer NV, Johnson & Johnson Consumer Saudi Arabia Limited, Johnson & Johnson Consumer Services EAME Ltd., Johnson & Johnson Del Paraguay S.A., Johnson & Johnson Dominicana S.A.S., Johnson & Johnson Enterprise Innovation Inc., Johnson & Johnson European Treasury Company, Johnson & Johnson Finance Corporation, Johnson & Johnson Finance Limited, Johnson & Johnson Financial Services GmbH, Johnson & Johnson Foundation Scotland (NON-PROFIT), Johnson & Johnson Gateway LLC, Johnson & Johnson Gesellschaft m.b.H., Johnson & Johnson GmbH, Johnson & Johnson Guatemala S.A., Johnson & Johnson Health Care Systems Inc., Johnson & Johnson Health and Wellness Solutions Inc., Johnson & Johnson Hellas Commercial and Industrial S.A., Johnson & Johnson Hellas Consumer Products Commercial Societe Anonyme, Johnson & Johnson Hemisferica S.A., Johnson & Johnson Holding GmbH, Johnson & Johnson Holdings K.K., Johnson & Johnson Inc., Johnson & Johnson Industrial Ltda., Johnson & Johnson Innovation - JJDC Inc., Johnson & Johnson Innovation LLC, Johnson & Johnson Innovation Limited, Johnson & Johnson International, Johnson & Johnson International (Singapore) Pte. Ltd., Johnson & Johnson International Financial Services Company, Johnson & Johnson Japan Inc., Johnson & Johnson K.K., Johnson & Johnson Kft., Johnson & Johnson Korea Ltd., Johnson & Johnson Korea Selling & Distribution LLC, Johnson & Johnson LLC, Johnson & Johnson Limitada, Johnson & Johnson Limited, Johnson & Johnson Luxembourg Finance Company Sarl, Johnson & Johnson Management Limited, Johnson & Johnson Medical (China) Ltd., Johnson & Johnson Medical (Proprietary) Ltd, Johnson & Johnson Medical (Shanghai) Ltd., Johnson & Johnson Medical (Suzhou) Ltd., Johnson & Johnson Medical B.V., Johnson & Johnson Medical Devices & Diagnostics Group - Latin America L.L.C., Johnson & Johnson Medical GmbH, Johnson & Johnson Medical Korea Ltd., Johnson & Johnson Medical Limited, Johnson & Johnson Medical Mexico S.A. de C.V., Johnson & Johnson Medical NV, Johnson & Johnson Medical Products GmbH, Johnson & Johnson Medical Pty Ltd, Johnson & Johnson Medical S.A., Johnson & Johnson Medical S.C.S., Johnson & Johnson Medical S.p.A., Johnson & Johnson Medical SAS, Johnson & Johnson Medical Saudi Arabia Limited, Johnson & Johnson Medical Servicios Profesionales S. de R.L. de C.V., Johnson & Johnson Medical Taiwan Ltd., Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi, Johnson & Johnson Middle East FZ-LLC, Johnson & Johnson Morocco Societe Anonyme, Johnson & Johnson Nordic AB, Johnson & Johnson Pacific Pty Limited, Johnson & Johnson Pakistan (Private) Limited, Johnson & Johnson Panama S.A., Johnson & Johnson Personal Care (Chile) S.A., Johnson & Johnson Poland Sp. z o.o., Johnson & Johnson Private Limited, Johnson & Johnson Pte. Ltd., Johnson & Johnson Pty. Limited, Johnson & Johnson Research Pty Ltd, Johnson & Johnson Romania S.R.L., Johnson & Johnson S.A., Johnson & Johnson S.A. de C.V., Johnson & Johnson S.E. Inc., Johnson & Johnson S.E. d.o.o., Johnson & Johnson SDN. BHD., Johnson & Johnson Sante Beaute France, Johnson & Johnson Services Inc., Johnson & Johnson Servicios Corporativos S. de R.L. de C.V., Johnson & Johnson Surgical Vision Inc., Johnson & Johnson Surgical Vision India Private Limited, Johnson & Johnson Taiwan Ltd., Johnson & Johnson UK Treasury Company Limited, Johnson & Johnson Ukraine LLC, Johnson & Johnson Urban Renewal Associates, Johnson & Johnson Vision Care (Shanghai) Ltd., Johnson & Johnson Vision Care Inc., Johnson & Johnson Vision Care Ireland Unlimited Company, Johnson & Johnson d.o.o., Johnson & Johnson de Argentina S.A.C. e. I., Johnson & Johnson de Chile Limitada, Johnson & Johnson de Chile S.A., Johnson & Johnson de Colombia S.A., Johnson & Johnson de Costa Rica S.A., Johnson & Johnson de Mexico S.A. de C.V., Johnson & Johnson de Uruguay S.A., Johnson & Johnson de Venezuela S.A., Johnson & Johnson del Ecuador S.A., Johnson & Johnson del Peru S.A., Johnson & Johnson do Brasil Industria E Comercio de Produtos Para Saude Ltda., Johnson & Johnson for Export and Import LLC, Johnson & Johnson s.r.o., Johnson and Johnson (Proprietary) Limited, Johnson and Johnson Sihhi Malzeme Sanayi Ve Ticaret Limited Sirketi, La Concha Land Investment Corporation, Latam International Investment Company Unlimited Company, LifeScan, MDS Co. Ltd., McNEIL MMP LLC, McNeil AB, McNeil Consumer Pharmaceuticals Co., McNeil Denmark ApS, McNeil Healthcare (Ireland) Limited, McNeil Healthcare (UK) Limited, McNeil Healthcare LLC, McNeil Iberica S.L.U., McNeil LA LLC, McNeil Nutritionals LLC, McNeil Panama LLC, McNeil Products Limited, McNeil Sweden AB, Medical Device Business Services Inc., Medical Devices & Diagnostics Global Services LLC, Medical Devices International LLC, Medical Industrial do Brasil Ltda., Medos International Sarl, Medos Sarl, MegaDyne Medical Products Inc., Menlo Care De Mexico S.A. de C.V., Mentor B.V., Mentor Deutschland GmbH, Mentor Medical Systems B.V., Mentor Partnership Holding Company I LLC, Mentor Texas GP LLC, Mentor Texas L.P., Mentor Worldwide LLC, Micrus Endovascular LLC, Middlesex Assurance Company Limited, Momenta Ireland Limited, Momenta Pharmaceuticals, Momenta Pharmaceuticals Inc., NeoStrata Company Inc., NeoStrata Company Inc., NeoStrata UG (haftungsbeschränkt), Netherlands Holding Company, NeuWave Medical Inc., Neuravi Inc., Neuravi Limited, Novira Therapeutics, Novira Therapeutics LLC, NuVera Medical Inc., OBTECH Medical Sarl, OGX Beauty AU Pty Ltd, OGX Beauty Limited, OMJ Holding GmbH, OMJ Ireland Unlimited Company, OMJ Pharmaceuticals Inc., Obtech Medical Mexico S.A. de C.V., Omrix Biopharmaceuticals Inc., Omrix Biopharmaceuticals Ltd., Omrix Biopharmaceuticals NV, Ortho Biologics LLC, Ortho Biotech Holding LLC, Ortho-McNeil Pharmaceutical LLC, Orthotaxy, Orthotaxy, PMC Holdings G.K., PT Integrated Healthcare Indonesia, PT. Johnson & Johnson Indonesia, Patriot Pharmaceuticals LLC, Peninsula Pharmaceuticals LLC, Penta Pty. Limited, Percivia LLC, Perouse Plastie, Pharmadirect Ltd., Pharmedica Laboratories (Proprietary) Limited, Princeton Laboratories Inc., Productos de Cuidado Personal y de La Salud de Bolivia S.R.L., Proleader S.A., Pulsar Vascular Inc., Regency Urban Renewal Associates, RespiVert Ltd., RoC International, Rutan Realty LLC, SYNTHES Medical Immobilien GmbH, Scios LLC, Sedona Enterprise Co. Ltd., Sedona Singapore International Pte. Ltd., Sedona Thai International Co. Ltd., Serhum S.A. de C.V., Shanghai Elsker For Mother & Baby Co. Ltd, Shanghai Johnson & Johnson Ltd., Shanghai Johnson & Johnson Pharmaceuticals Ltd., Sightbox LLC, Sodiac ESV, Spectrum Vision Limited Liability Company, Spectrum Vision Limited Liability Partnership, Spine Solutions GmbH, SterilMed, SterilMed Inc., Surgical Process Institute Deutschland GmbH, Synthes Costa Rica S.C.R. Limitada, Synthes GmbH, Synthes Holding AG, Synthes Holding Limited, Synthes Inc., Synthes Medical Surgical Equipment & Instruments Trading LLC, Synthes Produktions GmbH, Synthes Proprietary Limited, Synthes S.M.P. S. de R.L. de C.V., Synthes Tuttlingen GmbH, Synthes USA LLC, Synthes USA Products LLC, TARIS Biomedical, TARIS Biomedical LLC, TearScience Inc., The Anspach Effort LLC, The Vision Care Institute LLC, Tibotec LLC, Torax Medical Inc., TriStrata Incorporated, UAB "Johnson & Johnson", Vania Expansion, Verb Surgical, Verb Surgical Inc., Vision Care Finance Unlimited Company, Vogue International, Vogue International LLC, Vogue International Trading Inc., WH4110 Development Company L.L.C., XO1, XO1 Limited, Xian Janssen Pharmaceutical Ltd., Zarbee's Inc., and Zarbee's Naturals.

When was Johnson & Johnson founded?

Johnson & Johnson was founded in 1886.

What is Johnson & Johnson's official website?

The official website for Johnson & Johnson is www.jnj.com.

How can I contact Johnson & Johnson?

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The company can be reached via phone at (732) 524-0400 or via fax at 732-214-0332.

This page was last updated on 5/17/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.